Randomised trial of simulect versus placebo for control of acute rejection in renal allograft recipients
- 12 February 2003
- journal article
- clinical trial
- Published by Elsevier BV in Transplantation Proceedings
- Vol. 35 (1), 192-194
- https://doi.org/10.1016/s0041-1345(02)03769-7
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- REDUCTION OF THE OCCURRENCE OF ACUTE CELLULAR REJECTION AMONG RENAL ALLOGRAFT RECIPIENTS TREATED WITH BASILIXIMAB, A CHIMERIC ANTI-INTERLEUKIN-2-RECEPTOR MONOCLONAL ANTIBODY1,2Transplantation, 1999
- Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipientsThe Lancet, 1997